Increased CD163 expression is associated with acute-on-chronic hepatitis B liver failure

World Journal of Gastroenterology

Volumn 19, Issue 18, 2013, Pages 2818-2825

  Ye, Hong ^a   Wang, Li Yuan ^a   Zhao, Jing ^a   Wang, Kai ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Acute on chronic hepatitis B liver failure; CD163; Model for end stage liver disease; Real time transcription polymerase chain reaction; Soluble CD163

Indexed keywords

CD163 ANTIGEN; VIRUS DNA;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84877826449     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i18.2818     Document Type: Article

References (36)

1. Kitab B, Essaid El Feydi A, Afifi R, Trepo C, Benazzouz M, Essamri W, Zoulim F, Chemin I, Alj HS, Ezzikouri S, Benjelloun S. Variability in the precore and core promoter regions of HBV strains in Morocco: characterization and impact on liver disease progression. PLoS One 2012; 7: e42891 [PMID: 22905181 DOI: 10.1371/journal.pone.0042891]
2. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, de Silva HJ, Hamid SS, Jalan R, Komolmit P, Lau GK, Liu Q, Madan K, Mohamed R, Ning Q, Rahman S, Rastogi A, Riordan SM, Sakhuja P, Samuel D, Shah S, Sharma BC, Sharma P, Takikawa Y, Thapa BR, Wai CT, Yuen MF. Acuteon-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009; 3: 269-282 [PMID: 19669378 DOI: 10.1007/s12072-008-9106-x]
3. Huang K, Hu JH, Wang HF, He WP, Chen J, Duan XZ, Zhang AM, Liu XY. Survival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 2011; 17: 3448-3452 [PMID: 21876637 DOI: 10.3748/wjg.v17.i29.3448]
4. Wang LY, Meng QH, Zou ZQ, Fan YC, Han J, Qi ZX, Ge J, Xu AL, Wang SK, Wang K. Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure. Dig Dis Sci 2012; 57: 667-674 [PMID: 21984439 DOI: 10.1007/s10620-011-1930-5]
5. Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease. ScientificWorldJournal 2011; 11: 2391-2402 [PMID: 22194670 DOI: 10.1100/2011/213962]
6. Kowal K, Silver R, Sławińska E, Bielecki M, Chyczewski L, Kowal-Bielecka O. CD163 and its role in inflammation. Folia Histochem Cytobiol 2011; 49: 365-374 [PMID: 22038213]
7. Lin LN, Zhu Y, Che FB, Gu JL, Chen JH. Invasive fungal infections secondary to acute-on-chronic liver failure: a retrospective study. Mycoses 2013 Feb 1; Epub ahead of print [PMID: 23368965 DOI: 10.1111/myc.12044]
8. Zhang Z, Zou ZS, Fu JL, Cai L, Jin L, Liu YJ, Wang FS. Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure. J Hepatol 2008; 49: 396-406 [PMID: 18644645 DOI: 10.1016/j.jhep.2008.05.017]
9. Yang B, Wang Y, Zhao C, Yan W, Che H, Shen C, Zhao M. Increased Th17 cells and interleukin-17 contribute to immune activation and disease aggravation in patients with chronic hepatitis B virus infection. Immunol Lett 2013; 149: 41-49 [PMID: 23237940 DOI: 10.1016/j.imlet.2012.12.001]
10. Burdo TH, Lo J, Abbara S, Wei J, DeLelys ME, Preffer F, Rosenberg ES, Williams KC, Grinspoon S. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis 2011; 204: 1227-1236 [PMID: 21917896 DOI: 10.1093/infdis/jir520]
11. Fabriek BO, van Bruggen R, Deng DM, Ligtenberg AJ, Nazmi K, Schornagel K, Vloet RP, Dijkstra CD, van den Berg TK. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 2009; 113: 887-892 [PMID: 18849484 DOI: 10.1182/blood-2008-07-167064]
12. Shephard DA. The 1975 Declaration of Helsinki and consent. Can Med Assoc J 1976; 115: 1191-1192 [PMID: 1000449]
13. Etzerodt A, Maniecki MB, Graversen JH, Møller HJ, Torchilin VP, Moestrup SK. Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163. J Control Release 2012; 160: 72-80 [PMID: 22306335 DOI: 10.1016/j.jconrel.2012.01.034]
14. Tippett E, Cheng WJ, Westhorpe C, Cameron PU, Brew BJ, Lewin SR, Jaworowski A, Crowe SM. Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals. PLoS One 2011; 6: e19968 [PMID: 21625498 DOI: 10.1371/journal.pone.0019968]
15. Higashi-Kuwata N, Jinnin M, Makino T, Fukushima S, Inoue Y, Muchemwa FC, Yonemura Y, Komohara Y, Takeya M, Mitsuya H, Ihn H. Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis. Arthritis Res Ther 2010; 12: R128 [PMID: 20602758 DOI: 10.1186/ar3066]
16. He WP, Hu JH, Zhao J, Tong JJ, Ding JB, Lin F, Wang HF. Comparison of four prognostic models and a new Logistic regression model to predict short-term prognosis of acuteon-chronic hepatitis B liver failure. Chin Med J (Engl) 2012; 125: 2272-2278 [PMID: 22882847]
17. Zheng MH, Shi KQ, Fan YC, Li H, Ye C, Chen QQ, Chen YP. A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure. Clin Gastroenterol Hepatol 2011; 9: 351-356.e3 [PMID: 21195790 DOI: 10.1016/j.cgh.2010.12.027]
18. HJ. Soluble CD163. Scand J Clin Lab Invest 2012; 72: 1-13 [PMID: 22060747 DOI: 10.3109/00365513.2011.626868]
19. Møller HJ, Grønbaek H, Schiødt FV, Holland-Fischer P, Schilsky M, Munoz S, Hassanein T, Lee WM. Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J Hepatol 2007; 47: 671-676 [PMID: 17629586]
20. Shabo I, Svanvik J. Expression of macrophage antigens by tumor cells. Adv Exp Med Biol 2011; 714: 141-150 [PMID: 21506012 DOI: 10.1007/978-94-007-0782-5_7]
21. Onofre G, Kolácková M, Jankovicová K, Krejsek J. Scavenger receptor CD163 and its biological functions. Acta Medica (Hradec Kralove) 2009; 52: 57-61 [PMID: 19777868]
22. Davis BH, Zarev PV. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels. Cytometry B Clin Cytom 2005; 63: 16-22 [PMID: 15624200]
23. Hintz KA, Rassias AJ, Wardwell K, Moss ML, Morganelli PM, Pioli PA, Givan AL, Wallace PK, Yeager MP, Guyre PM. Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163. J Leukoc Biol 2002; 72: 711-717 [PMID: 12377940]
24. Weaver LK, Pioli PA, Wardwell K, Vogel SN, Guyre PM. Up-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors. J Leukoc Biol 2007; 81: 663-671 [PMID: 17164428]
25. Kneidl J, Löffler B, Erat MC, Kalinka J, Peters G, Roth J, Barczyk K. Soluble CD163 promotes recognition, phagocytosis and killing of Staphylococcus aureus via binding of specific fibronectin peptides. Cell Microbiol 2012; 14: 914-936 [PMID: 22309204 DOI: 10.1111/j.1462-5822.2012.01766.x]
26. Piatkowski A, Grieb G, Das R, Bozkurt A, Ulrich D, Pallua N. Soluble CD163: A novel biomarker for the susceptibility to sepsis in severe burn injuries. Indian J Plast Surg 2011; 44: 118-124 [PMID: 21713197 DOI: 10.4103/0970-0358.81454]
27. Burdo TH, Lentz MR, Autissier P, Krishnan A, Halpern E, Letendre S, Rosenberg ES, Ellis RJ, Williams KC. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. J Infect Dis 2011; 204: 154-163 [PMID: 21628670 DOI: 10.1093/infdis/jir214]
28. Jude C, Dejica D, Samasca G, Balacescu L, Balacescu O. Soluble CD163 serum levels are elevated and correlated with IL-12 and CXCL10 in patients with long-standing rheumatoid arthritis. Rheumatol Int 2013; 33: 1031-1037 [PMID: 23011084]
29. Fan HL, Yang PS, Chen HW, Chen TW, Chan DC, Chu CH, Yu JC, Kuo SM, Hsieh CB. Predictors of the outcomes of acute-on-chronic hepatitis B liver failure. World J Gastroenterol 2012; 18: 5078-5083 [PMID: 23049217 DOI: 10.3748/wjg. v18.i36.5078]
30. Feng L, Zhou X, Su LX, Feng D, Jia YH, Xie LX. Clinical significance of soluble hemoglobin scavenger receptor CD163 (sCD163) in sepsis, a prospective study. PLoS One 2012; 7: e38400 [PMID: 22911680 DOI: 10.1371/journal.pone.0038400]
31. Matsushita N, Kashiwagi M, Wait R, Nagayoshi R, Nakamura M, Matsuda T, Hogger P, Guyre PM, Nagase H, Matsuyama T. Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3. Clin Exp Immunol 2002; 130: 156-161 [PMID: 12296867]
32. Yan Y, Mai L, Zheng YB, Zhang SQ, Xu WX, Gao ZL, Ke WM. What MELD score mandates use of entecavir for ACLF-HBV HBeAg-negative patients? World J Gastroenterol 2012; 18: 4604-4609 [PMID: 22969236 DOI: 10.3748/wjg.v18.i33.4604]
33. Zhang Z, Zhang JY, Wang LF, Wang FS. [The relationship of HBeAg status with HBV DNA loads, MELD scores in patients with acute-on-chronic hepatitis B liver failure during terminal phases]. Zhonghua Shiyan He Linchuang Bingduxue Zazhi 2012; 26: 51-53 [PMID: 22919755]
34. Valisena S, Palumbo M, Parolin C, Palú G, Meloni GA. Relevance of ionic effects on norfloxacin uptake by Escherichia coli. Biochem Pharmacol 1990; 40: 431-436 [PMID: 2200406 DOI: 10.1111/j.1440-1746.2011.06940.x]
35. Su L, Feng L, Liu C, Jiang Z, Li M, Xiao K, Yan P, Jia Y, Feng D, Xie L. Diagnostic value of urine sCD163 levels for sepsis and relevant acute kidney injury: a prospective study. BMC Nephrol 2012; 13: 123 [PMID: 23013330 DOI: 10.1186/1471-2369-13-123]
36. Ingels C, Møller HJ, Hansen TK, Wouters PJ, Vanhorebeek I, Van den Berghe G. Circulating levels of the shed scavenger receptor sCD163 and association with outcome of critically ill patients. J Clin Immunol 2013; 33: 619-629 [PMID: 23150181 DOI: 10.1007/s10875-012-9830-9]